Literature DB >> 12631422

Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness.

Peter Bärtsch1, Erik R Swenson, André Paul, Bernhard Jülg, Elke Hohenhaus.   

Abstract

To examine whether sea-level hypoxic ventilatory responses (HVR) predict acute mountain sickness (AMS) and document temporal changes in ventilation, HVR, gas exchange, and fluid balance, we measured these parameters at low altitude (100 m) and daily during 3 days at high altitude (4559 m). At low altitude, there were no significant differences in rest or exercise isocapnic HVR, poikilocapnic HVR at rest, and hypercapnic ventilatory response between 12 subjects without significant AMS and 11 subjects who fell sick. No low altitude ventilatory responses correlated with AMS or fluid balance at high altitude. On day 1, isocapnic HVR was significantly lower in the AMS group [0.86 +/- 0.43 (SD) vs. 1.43 +/- 0.63 L/min/% Sa(O2), p < 0.05). AMS was associated with higher AaD(O2), lower Pa(O2), and Sa(O2), while Pa(CO2) was not different between subjects with and without AMS. Both groups showed equivalent reductions in urine volume, sodium output, and gain in body weight on day 1 while climbing to 4559 m, but on day 2 only subjects without AMS had diuresis, natriuresis, and weight loss. We conclude that (1) susceptibility to AMS, fluid balance, and ventilation at high altitude cannot be predicted by low altitude HVR testing and (2) that the failure to increase HVR on arrival at high altitude and impaired gas exchange, possibly due to interstitial edema, may account for the more severe hypoxemia in AMS.

Entities:  

Mesh:

Year:  2002        PMID: 12631422     DOI: 10.1089/15270290260512846

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  16 in total

1.  Prediction of the susceptibility to AMS in simulated altitude.

Authors:  Martin Burtscher; Christoph Szubski; Martin Faulhaber
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

2.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

3.  Basic medical advice for travelers to high altitudes.

Authors:  Kai Schommer; Peter Bärtsch
Journal:  Dtsch Arztebl Int       Date:  2011-12-09       Impact factor: 5.594

4.  Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia.

Authors:  Andrew W Subudhi; Andrew C Dimmen; Colleen G Julian; Megan J Wilson; Ronney B Panerai; Robert C Roach
Journal:  J Appl Physiol (1985)       Date:  2011-03-10

Review 5.  Respiratory responses to hypoxia during rest and exercise in individuals born pre-term: a state-of-the-art review.

Authors:  Grégoire P Millet; Tadej Debevec; Benjamin J Narang; Giorgio Manferdelli
Journal:  Eur J Appl Physiol       Date:  2022-05-19       Impact factor: 3.346

6.  The combined use of acetazolamide and Rhodiola in the prevention and treatment of altitude sickness.

Authors:  Chengzhu Cao; Huan Zhang; Yongchun Huang; Yameng Mao; Lan Ma; Shoude Zhang; Wei Zhang
Journal:  Ann Transl Med       Date:  2022-05

7.  Ventilatory Responsiveness during Exercise and Performance Impairment in Acute Hypoxia.

Authors:  Keren Constantini; Anna C Bouillet; Chad C Wiggins; Bruce J Martin; Robert F Chapman
Journal:  Med Sci Sports Exerc       Date:  2021-02-01       Impact factor: 5.411

8.  Right temporal cerebral dysfunction heralds symptoms of acute mountain sickness.

Authors:  Berend Feddersen; Harald Ausserer; Pritam Neupane; Florian Thanbichler; Antoine Depaulis; Robb Waanders; Soheyl Noachtar
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

9.  High-altitude illnesses: physiology, risk factors, prevention, and treatment.

Authors:  Andrew T Taylor
Journal:  Rambam Maimonides Med J       Date:  2011-01-31

10.  Normo or hypobaric hypoxic tests: propositions for the determination of the individual susceptibility to altitude illnesses.

Authors:  Gustave Savourey; Jean-Claude Launay; Yves Besnard; Angélique Guinet-Lebreton; Antonia Alonso; Fabien Sauvet; Cyprien Bourrilhon
Journal:  Eur J Appl Physiol       Date:  2007-02-24       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.